RT @BMCMedicine: .@JeanRampelbergh; @DrKathOwen and colleagues conduct a first in human intervention using IMCY-0098 on individuals living…
9 followers
37 followers
We are proud to announce the successful completion of a first-in-human, double-blind, randomized phase 1b study of peptide-based immunomodulatory therapy for the treatment of advanced solid tumors. The study, published in BMC Medicine, was designed to...
9,409 followers
.@JeanRampelbergh; @DrKathOwen and colleagues conduct a first in human intervention using IMCY-0098 on individuals living with recent onset type 1 diabetes. Read the full study here: https://t.co/YNBv5S7pY3 https://t.co/wgapEUCGU9